- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01766999
Methemoglobinemia After Liposuction - Diagnostic by Pulse Oximetry and Blood Gas Analysis.
Methemoglobinemia After Liposuction Under Tumescent Local Anesthesia - Timecourse and Diagnostics by Pulse Oximetry and Blood Gas Analysis.
Tumescent local anesthesia is a procedure which is frequently performed for plastic cosmetic surgical procedures such as liposuction. The subcutaneous adipose tissue is infiltrated with large volumes of a solution which also contain local anesthetics. However local anesthetics, can also lead to a marked production of methemoglobin. New generation pulse oximeters are able to measure SpMetHb non-invasivly.
The aim of this study is:
- to investigate multi-wavelength pulse oximetry as a monitoring method for patients at increased risk for methemoglobinemia.
- to illustrate MetHb concentrations over a course of 24 hours after a liposuction employing tumescent anesthesia has been carried out.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- planned liposuction in tumescent local anesthesia
Exclusion Criteria:
- hematologic disorders
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
SpMetHb > 8%
hemoximetric MetHb measurements triggered
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Correlation between hemoximetric and pulseoximetric measured methemoglobin
Time Frame: 24 hours
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Time course of MetHb concentration following liposuction employing tumescent anesthesia.
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MetHb02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Methemoglobinemia
-
Hospital Quality FoundationProve pharmCompletedMethemoglobinemia | Methemoglobinemia, AcquiredUnited States
-
American Regent, Inc.CompletedMethemoglobinemia | Congenital Methemoglobinemia
-
Nonin Medical, IncCompletedCollect Blood Values With Induced Hypoxia, Induced Methemoglobinemia, and Induced Hypoxia and MethemoglobinemiaUnited States
-
Loma Linda UniversityCompletedMethemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local AnestheticsMethemoglobinemiaUnited States
-
Provepharm SASCompletedAcquired MethaemoglobinaemiaFrance
-
Claudia SeilerCompletedAnemia | Side Effect | Methemoglobinemia | Iron DeficienciesSweden
-
University Medicine GreifswaldCompletedMethemoglobinemia | Linear IgA Bullous DermatosisGermany
-
Ordu UniversityMarmara University Pendik Training and Research HospitalCompletedAnemia, Iron-Deficiency | Methemoglobinemia | Parenteral Iron Therapy | Ferric CarboxymaltoseTurkey (Türkiye)
-
Vanderbilt UniversityNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Nonmalignant Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative Neoplasms | MethemoglobinemiaUnited States